Ex-FDA Tobacco Head Advising Company on Smoker Cessation (1)

A former head of the FDA’s tobacco center has joined the advisory board of a company developing a first-of-its-kind smoking cessation inhalation product that he says has the potential to be a “game changer” in lowering US tobacco use.

Mitch Zeller, who led the Center for Tobacco Products from March 2013 until his retirement in April 2022, is now providing policy and regulatory strategy consulting to Qnovia, Inc., a pharmaceutical company focused on inhaled therapeutics. The company is currently preparing an application to the Food and Drug Administration’s Center for Drug Evaluation and Research for a cessation therapy which, ...